Tag: pancreatic ductal adenocarcinoma

A new review maps how secreted protein circuits in gastrointestinal tumours govern immune recruitment, suppression and response to checkpoint immunotherapy.

A new glycoproteomic analysis shows that protein-residual N-glycosylation of extracellular matrix proteins marks a myCAF-enriched stromal state in pancreatic ductal ...

A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid ...

The phase 1 GlutaPanc trial shows that l-glutamine can be safely combined with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ...

Researchers in China have built and validated a predictive model that combines dual-energy CT spectral parameters with clinical indicators to ...

A new Nature Cancer study reveals how hypoxia-induced lactylation of MMSDH triggers ACSL4 degradation through propionylation, helping pancreatic cancer evade ...

Pancreatic cancer is one of the deadliest malignancies known to medicine, and its resistance to virtually every conventional therapy has ...

Pancreatic cancer has long been one of medicine's most stubborn adversaries, a disease so aggressive and so difficult to detect ...

Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies in modern oncology, with five-year survival rates that have barely ...

Oklahoma researchers have received a five-year, $2 million grant from the National Cancer Institute to investigate how pancreatic cancer alters ...